To Evaluate the Possible Benefit of Astaxanthin on Alzheimer Disease Clinical Trial
Official title:
Effect of Astaxanthin on the Patients With Alzheimer Disease
This study adapts a randomized, double-blind, placebo-controlled trial, to exam the possible benefit of Astaxanthin on Alzheimer disease. The enrolled Alzheimer patients will take Astaxanthin or placebo for 1 year. We will follow up Mini-Mental State Examination, Cognitive Ability Screening Instrument, Clinical Dementia Rating, and Neuropsychiatric Inventory at the end of the study.
This study aims to examine the benefit of Astaxanthin as adjuvant therapy for Alzheimer's disease. ;